DiaMedica Therapeutics Correlations
DMAC Stock | USD 5.44 0.20 3.55% |
The current 90-days correlation between DiaMedica Therapeutics and Puma Biotechnology is 0.17 (i.e., Average diversification). The correlation of DiaMedica Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
DiaMedica Therapeutics Correlation With Market
Significant diversification
The correlation between DiaMedica Therapeutics and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
DiaMedica |
Moving together with DiaMedica Stock
0.79 | DYAI | Dyadic International | PairCorr |
0.79 | ESPR | Esperion Therapeutics | PairCorr |
0.68 | DNA | Ginkgo Bioworks Holdings | PairCorr |
Moving against DiaMedica Stock
0.74 | ERNA | Eterna Therapeutics | PairCorr |
0.7 | VALN | Valneva SE ADR | PairCorr |
0.67 | SLS | Sellas Life Sciences | PairCorr |
0.54 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.51 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.51 | GNFT | Genfit | PairCorr |
0.31 | LLY | Eli Lilly | PairCorr |
0.31 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.68 | AMGN | Amgen Inc | PairCorr |
0.58 | RANI | Rani Therapeutics | PairCorr |
0.53 | MBIO | Mustang Bio | PairCorr |
0.48 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.47 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.46 | MRVI | Maravai Lifesciences | PairCorr |
0.41 | INKT | Mink Therapeutics | PairCorr |
0.39 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.66 | TFFP | Tff Pharmaceuticals | PairCorr |
0.6 | AVDL | Avadel Pharmaceuticals | PairCorr |
0.52 | TCRX | Tscan Therapeutics | PairCorr |
0.51 | APGE | Apogee Therapeutics, | PairCorr |
0.5 | SNDL | SNDL Inc | PairCorr |
0.49 | AQST | Aquestive Therapeutics | PairCorr |
Related Correlations Analysis
-0.02 | 0.19 | -0.7 | 0.0 | -0.18 | -0.16 | PBYI | ||
-0.02 | 0.7 | 0.51 | 0.08 | 0.79 | 0.78 | IOVA | ||
0.19 | 0.7 | 0.32 | 0.19 | 0.75 | 0.62 | DAWN | ||
-0.7 | 0.51 | 0.32 | 0.0 | 0.64 | 0.65 | INZY | ||
0.0 | 0.08 | 0.19 | 0.0 | 0.0 | -0.04 | ZNTL | ||
-0.18 | 0.79 | 0.75 | 0.64 | 0.0 | 0.77 | SNDX | ||
-0.16 | 0.78 | 0.62 | 0.65 | -0.04 | 0.77 | PTGX | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between DiaMedica Stock performing well and DiaMedica Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DiaMedica Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PBYI | 2.79 | 0.16 | 0.04 | 0.20 | 4.63 | 5.17 | 33.65 | |||
IOVA | 3.31 | (0.38) | 0.00 | (0.07) | 0.00 | 7.54 | 23.06 | |||
DAWN | 2.03 | (0.23) | 0.00 | (0.13) | 0.00 | 3.71 | 11.05 | |||
INZY | 3.07 | (0.90) | 0.00 | (0.61) | 0.00 | 6.76 | 16.62 | |||
ZNTL | 4.34 | (0.13) | 0.00 | 0.05 | 5.43 | 11.41 | 33.76 | |||
SNDX | 2.50 | (0.69) | 0.00 | (0.12) | 0.00 | 4.02 | 34.00 | |||
PTGX | 1.99 | (0.28) | 0.00 | (0.09) | 0.00 | 3.42 | 16.19 |
DiaMedica Therapeutics Corporate Management
MS MD | Independent Consultant | Profile | |
Scott CA | CFO Sec | Profile | |
Edward Calamai | Consulting Manufacturing | Profile | |
Ambarish Shah | Chief Officer | Profile | |
Lorianne MD | Chief Officer | Profile | |
Julie CCRP | Senior Operations | Profile |